APA (7th ed.) Citation

EB, K., JE, M., M, L., SS, H., CW, M., AR, B., . . . AJ, Y. (2025). Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury. Blood advances, 9(13), 3129. https://doi.org/10.1182/bloodadvances.2025015901

Chicago Style (17th ed.) Citation

EB, Kim, et al. "Early Daratumumab Therapy Improves Renal Outcomes in Newly Diagnosed Patients with Myeloma Admitted with Kidney Injury." Blood Advances 9, no. 13 (2025): 3129. https://doi.org/10.1182/bloodadvances.2025015901.

MLA (9th ed.) Citation

EB, Kim, et al. "Early Daratumumab Therapy Improves Renal Outcomes in Newly Diagnosed Patients with Myeloma Admitted with Kidney Injury." Blood Advances, vol. 9, no. 13, 2025, p. 3129, https://doi.org/10.1182/bloodadvances.2025015901.